James Investment Research’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
II
CW
PFG
CFD
LI
James Investment Research's IBD Position: Q2 2023 in Review
James Investment Research sold out of Inspire Corporate Bond ETF (IBD) in Q2 2023, closing a stake of 3,129 shares — an estimated $73K sold.
James Investment Research first reported a position in IBD in Q1 2018 and held it in 21 quarters. The position peaked at $73K in Q1 2023. 52 funds tracked by Wall St. Rank hold IBD as of Q2 2023.
- James Investment Research reported no remaining Inspire Corporate Bond ETF position as of Q2 2023 after selling out during the quarter.
- James Investment Research sold 3,129 Inspire Corporate Bond ETF shares in Q2 2023, an estimated $73K.
- James Investment Research first reported a position in Inspire Corporate Bond ETF in Q1 2018 and held it in 21 quarters.
- James Investment Research's Inspire Corporate Bond ETF position peaked at $73K in Q1 2023.
- 52 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2023.
Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.